Entering home medical care, and challenging the separation of practice from management (1994)
A wall of regulation, and a wager on trust
The heart of this entry was not marching into a lucrative market but working out how to build a foothold in a territory protected by regulation. With the Medical Service Act barring corporate entry and a hard line drawn around what non-physicians may do, Secom used detours — home infusion therapy, hospital turnarounds — to force the institutional side into a debate about separating medical practice from business management. As chairman Iida saw it, this was a contest of trust: the logic of entry rested not on near-term returns but on the durable first-mover advantage available to whoever earns that trust first. In a setting where regulation and business judgement are entangled, it was a decision to step deliberately onto the edge of the system.
Yet “first-mover advantage,” turned around, is also a phrase that can justify years of losses. With patient numbers far below target and the business in the red, sustaining a ten- or twenty-year horizon was a posture available only so long as the core security business kept generating ample profit. Medicine and nursing care did eventually grow into one of Secom’s pillars — but that owed as much to the tailwind of an ageing society and to the strength of the business underwriting it. Carrying a loss-making venture while waiting for regulation to move was a choice open to Secom precisely because its core business was strong.
Revenue and net margin, FY1989–FY1999
Revenue in ¥ bn (bars) and net margin in % (line), for the years around the decision. Shaded columns are FY1994 onwards — after it was taken.
Source: securities reports
Read the full dossier in Japanese →
The Japanese edition carries the complete record of this decision — the situation that forced it, the options weighed, what actually followed, and the sources behind every claim.
Other key decisions at Secom
Yen amounts are converted at the average rate of each figure’s own year — not today’s rate; the revenue chart is shown in yen. Exchange rates & sources — the full ¥/US$ table →
Disclaimer
- This page is provided for general information only and is not investment advice, nor a recommendation to buy or sell any security.
- Figures are compiled independently and include our own estimates, approximations and machine-processed data; we make no warranty as to their accuracy or completeness.
- Sources are primarily each company’s securities reports and other public filings, but errors and omissions may remain.
- Any use of this information is at the reader’s own risk. Past performance does not indicate future results.
- Company names, logos and other marks belong to their respective owners.
Data API
Secom’s history, financials, executives and
shareholders are published as static JSON — no key, plain GET.
Full specification →
| Method | Endpoint | Returns |
|---|---|---|
| GET | /api/companies.json | All companies |
| GET | /api/9735/manifest.json | Resource index |
| GET | /api/9735/history.json | History overview |
| GET | /api/9735/timeline.json | Chronology |
| GET | /api/decisions.json | All management decisions (index) |
| GET | /api/9735/decisions.json | Management decisions (index) |
| GET | /api/9735/decisions/{slug}.json | One decision (full dossier) |
| GET | /api/9735/executives.json | Executives |
| GET | /api/9735/shareholders.json | Major shareholders |
| GET | /api/9735/financials.json | Financial statements |
| GET | /api/9735/financials-longterm.json | Long-term results |
| GET | /api/9735/segments.json | Business segments |
| GET | /api/9735/regions.json | Sales by region |
| GET | /api/9735/workforce.json | Workforce |